Loading…
DIA Europe 2019 has ended
View analytic
Tuesday, February 5 • 11:00 - 12:30
#DMD1: European Regulatory Town Hall Meeting – Key Topics for the Future

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session

• Status of telematic implementation • Timely access to medicine • Availability of medicinal products • First look at ideas for Strategy 2021 – 2025

Chair

Christa Wirthumer-Hoche, PhD

Speaker

Panel Discussion
Nicola Bedlington

Panel Discussion
Karl Broich, DrMed

Panel Discussion
Nathalie Moll

Panel Discussion
Guido Rasi, MD

Panel Discussion
Thomas Senderovitz, DrMed, MD



Speakers
avatar for Karl Broich

Karl Broich

President, Federal Institute for Drugs and Medical Devices (BfArM)
Physician, MD (certifications in Neurology, Psychiatry, Behavioural Psychotherapy). BfArM in Bonn (Germany): 2000 to 2014 several executive functions, since 08/2014 head (President). Work in several EMA committees; chair of CNS-Working Party. Current research: clinical trials methodology... Read More →
avatar for Harald Enzmann

Harald Enzmann

Chair, CHMP; Head of European and International Affairs, Federal Institute for Drugs and Medical Devices (BfArM)
Harald Enzmann is chairperson of EMA’s Committee for Medicinal Products for Human Use (CHMP). A physician by training, Harald held positions at the German Cancer Research Center (dkfz), at the Intitute of Pharmacology and Toxicology at the University of Erlangen, at R&D at Bayer... Read More →
NM

Nathalie Moll

Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
avatar for Guido Rasi

Guido Rasi

Executive Director, European Medicines Agency (EMA)
Prof Guido Rasi began his second term as Executive Director of EMA on 16 November 2015. From November 2014 to mid-November 2015, he served as EMA’s Principal Adviser in Charge of Strategy. From November 2011 to November 2014 he was the Executive Director of the EMA and a member... Read More →
avatar for Thomas Senderovitz

Thomas Senderovitz

Chair of HMA Management Group; Director General, Danish Medicines Agency
Thomas Senderovitz took over as Director General of the Danish Medicines Agency on 1 April 2016. His career includes more than 20 years working with medicinal products and he has held several senior positions in international biopharmaceutical Companies. He previously worked at the... Read More →
avatar for Christa Wirthumer-Hoche

Christa Wirthumer-Hoche

Chair, EMA Management Board, Head, Austrian Medicines and Medical Devices Agency
Christa Wirthumer-Hoche studied biochemistry TU Vienna, doctoral thesis at Medical Physiology. Starting at the AT Nat. Inst. for Quality Control of Drugs - quality assessment, Head of Regulatory Affairs in the Ministry of Health, Now Head of the Austrian Medicines and Medical Devices... Read More →
avatar for Nicola Bedlington

Nicola Bedlington

Secretary General, European Patient's Forum
Nicola Bedlington was first Executive Director of the European Patients’ Forum (EUPATI), which she continues to serve as its Secretary General, and is co-founder of Patients Access Partnership (PACT). She previously provided leadership to the Swiss government’s Environment and... Read More →


Tuesday February 5, 2019 11:00 - 12:30
Hall D Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  • Featured Topics Regulatory Science
  • Tags Session